Trials / Unknown
UnknownNCT02475928
Zinc Supplementation in Cirrhotic Patients
Zinc Supplementation as Treatment of Dysgeusias in Cirrhotic Patients
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- Fundación Clínica Médica Sur · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effect of zinc supplementation in the treatment for dysgeusia, progression disease and quality of life in patients with liver cirrhosis.
Detailed description
Taste disorders are symptomatologies in patients with cirrhosis, these have a direct effect in modification of food consumption, increasing weight loss, anorexia and malnutrition, which impacts in decompensation rates and mortality. It has been proposed that zinc deficiency is one of the causes for development of taste disorders. The aim of this study is to describe the presence of taste disorders in patients with cirrhosis and evaluate the effect of zinc supplementation in treatment of taste disorders, and in progression of chronic liver disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | zinc gluconate | Zinc supplementation plus nutritional education |
| DIETARY_SUPPLEMENT | Placebo | |
| BEHAVIORAL | Nutritional education |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2019-12-01
- Completion
- 2019-12-01
- First posted
- 2015-06-19
- Last updated
- 2019-02-15
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT02475928. Inclusion in this directory is not an endorsement.